Catalent competitors & alternatives

Catalent Inc is a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, and consumer health products. As a critical partner in the pharmaceutical supply chain, Catalent helps innovators bring complex therapies to market faster. Because of the high stakes in drug development, companies frequently compare Catalent against other CDMO alternatives to ensure they have the right technical capabilities, manufacturing capacity, and regulatory compliance for their specific molecule. Whether evaluating specialized drug delivery platforms or large-scale commercial manufacturing, understanding the competitive landscape is essential for pharmaceutical firms looking to optimize their outsourcing strategy and accelerate their clinical pipelines.

Top Catalent competitors

Catalent competitors include Lonza, Thermo Fisher Scientific, Samsung Biologics, WuXi Biologics and Recipharm.

12 Alternatives

Lonza

Biologics CDMO ProviderEnterprise

Lonza competes with Catalent in the high-growth biologics manufacturing space. While Catalent focuses heavily on drug delivery technologies and oral dose forms, Lonza offers superior large-scale mammalian cell culture capabilities. Buyers often choose Lonza for complex clinical-to-commercial biologics projects requiring deep technical expertise in cell line development and viral vector manufacturing.

Thermo Fisher Scientific

Integrated Pharma ServicesEnterprise

Thermo Fisher competes with Catalent through its Patheon division, providing end-to-end drug development and manufacturing. Unlike Catalent, which specializes in proprietary delivery platforms, Thermo Fisher leverages its massive supply chain and analytical instrument ecosystem. This makes it a preferred partner for companies seeking a single-source provider for both equipment and manufacturing.

Samsung Biologics

Biopharmaceutical ManufacturingEnterprise

Samsung Biologics competes with Catalent in the global CDMO market, specifically for large-scale monoclonal antibody production. While Catalent emphasizes flexible, smaller-batch clinical supply, Samsung Biologics differentiates itself through massive, rapid-scale capacity and operational efficiency. Clients choose Samsung when they require rapid scaling of commercial-stage biologics with high-volume manufacturing requirements.

WuXi Biologics

Biologics CDMOEnterprise

WuXi Biologics competes with Catalent in the early-stage drug development pipeline. While Catalent provides integrated clinical supply services, WuXi Biologics is known for its highly accelerated 'CRDMO' model that shortens development timelines. Clients choose WuXi for its speed-to-market advantage and deep integration across the entire drug discovery and development lifecycle.

Recipharm

Contract Development and ManufacturingEnterprise

Recipharm competes with Catalent in the European market for small molecule drug development. Unlike Catalent’s focus on advanced drug delivery technologies like softgels, Recipharm offers a broader range of standard dosage forms and packaging solutions. Buyers often select Recipharm for its cost-effective, reliable manufacturing footprint across diverse European regulatory environments.

Unlock Full Company Details and Decision-Maker Insights

Tech stack categories related to Catalent

Explore how different tools are grouped across the tech stack based on their primary functions and use cases.

Drug Delivery Technology Platforms

Specialized proprietary technologies for optimizing drug absorption and patient compliance.

Biologics Manufacturing Services

Platforms for large-scale production of complex biological drugs and therapies.

Clinical Supply Chain Solutions

End-to-end logistics and packaging services for global clinical trial management.

Market overview

The CDMO market is highly fragmented, with competition driven by specialized technical capabilities, global manufacturing capacity, and regulatory track records. Companies must weigh the benefits of Catalent's proprietary delivery technologies against the scale and integrated service models offered by major competitors. Explore Catalent’s funding and financial details.

Why users choose Catalent

  • Proprietary drug delivery technologies like softgel and Zydis
  • Extensive global network of clinical supply facilities
  • Deep expertise in complex molecule development
  • Strong track record in regulatory compliance and quality

Why users switch to alternatives

  • Need for larger-scale commercial manufacturing capacity
  • Desire for a more integrated, single-source service provider
  • Seeking lower-cost manufacturing options for mature products
  • Requirement for specific regional manufacturing footprints
  • Preference for alternative proprietary delivery platforms

Discover competitor landscapes for other companies

Covista
Telecom Services ProviderEnterprise

Covista Inc provides essential telecommunications services, including voice, data, and managed network solutions tailored for business operations. As organizations increasingly shift toward cloud-based communication and integrated digital infrastructure, many businesses evaluate Covista Inc against various competitors and alternatives to ensure their connectivity needs align with modern scalability and performance requirements. Whether seeking traditional reliability or advanced AI-driven communication features, understanding the landscape of telecom providers is critical for decision-makers. This guide helps you compare Covista Inc with top industry alternatives, highlighting key differentiators in service, technology, and enterprise capabilities to help you choose the right partner for your business communication strategy.

Bayerischer Rundfunk
Public Service BroadcasterEnterprise

Bayerischer Rundfunk (BR) is a prominent public service broadcaster based in Munich, serving as a key member of the ARD network. It provides a wide array of television, radio, and digital content, focusing on regional news, culture, education, and entertainment for the state of Bavaria. Users often search for competitors and alternatives to BR to compare its regional reporting depth, digital accessibility, and public service mandate against other national broadcasters, commercial media groups, and modern streaming platforms. Understanding these alternatives helps audiences navigate the diverse German media landscape, whether they are seeking localized information or broader national and international perspectives.

United International Enterprises
Diversified Investment Holding CompanyEnterprise

United International Enterprises Ltd (UIE) is a holding company primarily focused on the agro-industrial sector, with significant investments in vegetable oil production and related food processing industries. As a conglomerate, UIE is frequently evaluated by investors seeking alternatives that offer long-term capital appreciation through diversified industrial holdings. When researching competitors or alternatives, stakeholders compare UIE against other investment firms that balance stable, commodity-linked cash flows with strategic growth initiatives. Understanding these competitors is essential for investors looking to benchmark UIE’s performance, dividend policy, and portfolio concentration against other major European holding companies and specialized agro-industrial investment vehicles.

TRATON
Commercial Vehicle ManufacturingEnterprise

TRATON is a global leader in the commercial vehicle industry, managing a portfolio of brands including Scania, MAN, Volkswagen Truck & Bus, and Navistar. As a major player in the manufacturing of heavy-duty trucks, buses, and transport solutions, TRATON is frequently evaluated by fleet managers and logistics companies seeking to compare its modular engineering capabilities against other global manufacturers. Users often research competitors and alternatives to TRATON to assess differences in total cost of ownership, electrification roadmaps, and regional service support, ensuring their fleet investments align with specific operational requirements and long-term sustainability goals in the competitive global transport market.

Schön Klinik
Specialized Healthcare ProviderEnterprise

Schön Klinik is a leading private hospital group in Germany, renowned for its high-quality specialized care in orthopedics, neurology, and psychosomatics. Patients and healthcare partners often compare Schön Klinik to other major hospital networks when seeking specialized treatment centers or elective surgical procedures. Understanding the landscape of competitors is essential for patients evaluating clinical outcomes, facility accessibility, and specialized medical expertise. Whether you are looking for alternatives to Schön Klinik’s specific rehabilitation programs or comparing general hospital infrastructure, this analysis highlights the top providers in the German healthcare market to help you make an informed decision regarding your medical care.

MANN+HUMMEL
Filtration Technology SolutionsEnterprise

Mann+Hummel is a global leader in filtration technology, providing innovative solutions for automotive, industrial, and life science applications. As organizations seek to optimize air and liquid quality, they often compare Mann+Hummel against other industry leaders to ensure performance, durability, and regulatory compliance. Whether you are looking for alternatives for heavy-duty engine filtration or specialized industrial air purification, understanding the competitive landscape is essential. This guide helps you compare Mann+Hummel with top competitors, highlighting key differences in product focus, engineering capabilities, and market applications to help you make an informed decision for your specific filtration requirements.

Frequently Asked Questions About Catalent Competitors

Who are the main competitors of Catalent?
The main competitors of Catalent include Lonza, Thermo Fisher Scientific, and Samsung Biologics. Each competitor links to its company profile page.
What are some alternatives to Catalent?
Alternatives to Catalent include companies such as Samsung Biologics, WuXi Biologics, and Recipharm.
Which companies compete with Catalent?
Other companies that compete with Catalent include Recipharm.